An Analysis of monocyte/macrophage subsets and granulocyte-macrophage colony-stimulating factor expression in renal allograft biopsies?

Nephron

Volumn 73, Issue 4, 1996, Pages 536-543

  Kajiwara, Ichiro ^a   Kawamura, Koji ^a   Takebavashi, Shigeo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Acute rejection; Granulocyte macrophage colony stimulating factor; Macrophage; Renal transplantation

Indexed keywords

AVIDIN; BIOTIN; CD11B ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAM56 ANTIGEN; HLA DR ANTIGEN; LEU M3 ANTIGEN; MONOCLONAL ANTIBODY; OKM5 ANTIGEN; PEROXIDASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY GRAFT REJECTION; KIDNEY TUBULE EPITHELIUM; MACROPHAGE; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CHILD; FEMALE; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES;

EID: 0029759130     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189137     Document Type: Article

References (31)

1. Solez K. Racusen LC, Marcussen N. Slatnik I, Kcown P. Burdic JF. Oslen S: Morphology of ischemic acute renal failure, normal function, and cyclosporinc toxicity in cyclosporine-trcated renal allograft recipients. Kidney Int 1993:43:1058-1067.
2. Van Es A. Meyer CJLM. Oljans PJ. Tanke HJ. van Es LA: Mononuclear cells in renal allografts. Transplantation 1984;37:134-139.
3. Bogman MJJT, Doopcr IMM. van de Winkel JGJ. Tax WJM. Hoitsma AJ. Assmann KJM. Ruiter DJ. Kocnc RAP: Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody. WT14. Lancet 1989:0:235-238.
4. Hall BM. Bishop GA. Duggin GG, Horvath JS. Philips J. Tiller DJ: Increased expression of HLA-DR antigens or renal tubular cells in renal transplants: Relevance to the rejection response. Lancet 1984;ii:247-251.
5. Häyry P. von Willebrand E. Ahoncn J. Eklund B. Lautenschlagcr I: Monitoring of organ allograft rejection by transplant aspiration cytology. Ann Clin Res 1981;13:264-287.
6. von Willebrand E. Pettersson E. Ahoncn J, Häyry P: CMV infection, class II antigen expression. and human kidney allograft rejection. T ransplantat ion 1986:42:364-367.
7. Philip R. Epstein LB: Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, y-interferon and interleukin-1. Nature 1986:323:86-89.
8. Cameron DJ: Macrophage-mediated tumor cytotoxicity. Function of macrophages in human renal allograft recipients. Jpn J Exp Med 1983; 53:19-26.
9. Hancock WW, Thomson NM, Atkins RC: Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983;35:458-463.
10. von Willcbrand E. Häyry P: Composition and in vitro cytotoxicity of cellular infiltrates in rejecting human kidney allografts. Cell Immunol 1978;41:358-372.
11. MacPherson GG. Christmas SE: The role of the macrophage in cardiac allograft rejection rat. Immunol Rev 1984;77:143-166.
12. Raftcry MJ. Serón D. Koffman G. Hartley B. Janossy G, Cameron JS: The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantat ion 1989:48:238-243.
13. Clark SC. Kamen R: The human hematopoietic colony-stimulating factors. Science 1987: 236:1229-1237.
14. Nakata K, Akagawa KS, Fukayama M. Hava-shi Y. Kadokura M. TokunagaT: Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J Immunol 1991; 147:1266-1272.
15. Solez K. Axelsen RA. Benediktsson H. el al: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993:44:411-422.
16. Nanba K, Aôki J, Sasaki N: A new enzyme immunohistochemical technique using alkaline phosphatase-labeled avidin and new fuch-sin (in Japanese). Pathol Clin Med 1987;5: 333-339.
17. Wamke RA. Pulford KAF, Pallesen G. Ralf-kiaer E, Brown DC, Gaiter KC, Mason DY: Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol 1989;135:1089-1095.
18. Ross GD, Cain JA. Lachmann PJ: Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglu-tinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol 1985;134:3307-3315.
19. Dimitriu-Bona A. Burmester GR, Waters SJ, Winchester RJ: Human mononuclear phagocyte differentiation antigens. I. Pattern of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J Immunol 1983:130:145-152.
20. Knowles DM, Tolidjian B. Marboc C. d'Agali V. Grimes M. Chess L: Monoclonal anti-hu-man monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium. J Immunol 1984:132:2170-2173.
21. Gown AM, Tsukada T. Ross R: Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986:125:191-207.
22. Wamke RA. Gatter KC. Falini B. Hildreth P. Woolston R-E, Pulford K: Diagnosis of human lymphoma with monoclonal anti-leukocyte antibodies. N Engl J Med 1983;309:1275-1281.
23. Smith MEF. Holgate CS. Williamson JMS. Grigor I. Quirke P. Bird CC: Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin’s lymphoma. J Clin Pathol 1987;40:34-41.
24. Hirotaka S. Nakane Y. Okino K. Nishihara K. Kodama M. Paku K, Takayama H. Tomoyoshi T. Kawata M. Yarnada H: Immunohistochemical study of the cells infiltrating human renal allografts by the ABC and the 1GSS method using monoclonal antibodies. Transplantation 1987:44:43-50.
25. Benson A. Ziegler HK: Macrophages as targets for inhibition by cyclosporinc. Transplantation 1989:47:696-703.
26. McIntosh LC, Thompson AW: Activity of the mononuclear phagocyte system in cyclosporine A-treated mice. Transplantation 1980;30:384-386.
27. Metcalf D: The granulocyte-macrophage colony-stimulating factor. Science 1985:229:16-22.
28. Thorens B. Mermod JJ. Vassalli P: Phagocytosis and inflammatory stimuli induced GM-CSF mRNA in macrophages through posttranscrip-tional regulation. Cell 1987:48:671-679.
29. Collar! MA. Bclin D. Vassalli JD. Kossoda S, Vassalli P: y-Interfcron enhances macrophage transcription of the tumor necrosis factor/ca-chectin. interleukin-1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986;164:2113-2118.
30. Rizzo MT, Boswell HS: Regulation of interleukin-1 and tumor necrosis factor-a induced granulocyte-macrophage colony-stimulating factor gene expression: Potential involvement of arachidonic acid metabolism. J Exp Hematol 1994;22:87-94.
31. Reitamo S. Konttinen YT. Ranki A. Häyry P: The relation of different inflammatory cell types to the various parenchymal components of rejecting kidney allografts. Histopathology 1980;4:517-532